Moberg Pharma AB | Ownership
Companies that own Moberg Pharma AB
Östersjöstiftelsen
2,274,179
12.85%
0
50.21%
03/29/2018
Armistice Capital LLC
1,746,000
9.86%
870,000
0.71%
01/09/2018
Grandeur Peak Global Advisors LLC
625,909
3.54%
-75,042
0.1%
03/29/2018
Danica Pension Livsforsikrings A/S
100,720
0.56%
-17,295
0.16%
03/29/2018
SEB Investment Management AB
45,670
0.26%
0
0%
12/31/2017
Skandia Investment Management AB
8,323
0.05%
0
0%
07/31/2018
Catella Fondförvaltning AB
3,600
0.02%
0
0%
08/31/2018
Xact Kapitalförvaltning AB
7
0%
-81,461
0%
08/31/2018
Granit Fonder AB
0
0%
-29,000
0%
12/31/2017
Strand Kapitalförvaltning AB
0
0%
-125,000
0%
06/30/2017
| Address |
Gustavslundsvägen 42, 5 tr
Bromma AB 167 51
Sweden
|
|
Employees
|
- |
| Website |
http://www.mobergpharma.se |
| Updated |
07/08/2019 |
| Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. It offers its products through the following brands: Kerasal, Kerasal Nail, Balmex, NewSkin, Dermoplast, Domeboro, and Fiber Choice. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden. |
